Differences between revisions 5 and 10 (spanning 5 versions)
Revision 5 as of 2011-03-03 16:46:29
Size: 1387
Editor: PietMolenaar
Comment: Simplifying
Revision 10 as of 2011-09-01 21:40:14
Size: 400
Editor: alsace
Comment:
Deletions are marked like this. Additions are marked like this.
Line 1: Line 1:
## page was renamed from Cytoscape_3/Background
## page was renamed from RFC Template
= Cytoscape 3.0 Core Developer Documentation =
This documentation provides much of the low-level detail needed to understand Cytoscape 3.0 Core development.
Line 4: Line 4:
|| '''Cytoscape 3 Documentation''' : Background information|| '''Editor(s)''': MikeSmoot || '''Date''': February 25th 2011 ||'''Status''': Created pages ||

<<TableOfContents(2)>>

== Purpose ==
Here documentation is gathered providing a general background to Cytoscape

== Cytoscape 3: Motivation ==
 * [[/Architecture|Cytoscape 3 Architecture]]
Line 13: Line 6:

== Architecture ==
 * [[/Architecture|Cytoscape 3 Architecture]]

== API ==
Line 19: Line 7:

== Debugging ==
Line 22: Line 8:

=== Issues ===
~-''List any issues, conflict, or dependencies raised by this proposal''-~

=== Comments ===
##If you want to create a separate subpage for Comments, then provide this link: ["/Comment"]

 *''Add comment here…''

==== How to Comment ====
Edit the page and add your comments under the provided header. By adding your ideas to the Wiki directly, we can more easily organize everyone's ideas, and keep clear records. Be sure to include today's date and your name for each comment. '''Try to keep your comments as concrete and constructive as possible. For example, if you find a part of the documentation makes no sense, please say so, but don't stop there. Take the extra step and propose alternatives.'''
 * [[/AutomatedTesting|Automated Testing]]

Cytoscape 3.0 Core Developer Documentation

This documentation provides much of the low-level detail needed to understand Cytoscape 3.0 Core development.

Cytoscape_3/CoreDevelopment (last edited 2016-07-14 18:16:22 by AlexPico)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux